The law firm of Hissey Kientz, LLP wishes to commend the Food and Drug Administration for its ongoing safety review of the health risks associated with the type-2 diabetes drug Avandia. The agency is currently reviewing whether to remove Avandia from the U.S. market after an FDA advisory panel voted to place new restrictions on its use and to make revisions to the warning label that accompanies …
Comments on this entry are closed.